awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33823212-4DE9E016-C1DD-4A93-AB49-70BE1BF2E662
Q33823212-4DE9E016-C1DD-4A93-AB49-70BE1BF2E662
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33823212-4DE9E016-C1DD-4A93-AB49-70BE1BF2E662
FOLFOX as second-line chemotherapy in patients with pretreated metastatic pancreatic cancer from the FIRGEM study
P2860
Q33823212-4DE9E016-C1DD-4A93-AB49-70BE1BF2E662
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33823212-4DE9E016-C1DD-4A93-AB49-70BE1BF2E662
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
75bf27adfa1b45e7724ae977580cf1d21129d20d
P2860
Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.